This paper was funded by: Funded Access, Leverhulme Trust. Grant Number: RPG-2012-504, TSB. Grant Number: 131181, ERC. Grant Number: 339367, and BBSRC. Grant Number: BB/K015508/1Heterocycle-containing cyclic peptides are promising scaffolds for the pharmaceutical industry but their chemical synthesis is very challenging. A new universal method has been devised to prepare these compounds by using a set of engineered marine-derived enzymes and substrates obtained from a family of ribosomally produced and post-translationally modified peptides called the cyanobactins. The substrate precursor peptide is engineered to have a non-native protease cleavage site that can be rapidly cleaved. The other enzymes used are heterocyclases that convert Cys ...
This work was supported by the European Research Council (339367), UK Biotechnology and Biological S...
Acknowledgements This work was supported by the European Research Council (339367), UK Biotechnology...
Supported by a Wellcome Trust Capital Award (086036)Ringing the changes: Selenazolines have applicat...
Heterocycle‐containing cyclic peptides are promising scaffolds for the pharmaceutical industry but t...
Heterocycle-containing cyclic peptides are promising scaffolds for the pharmaceutical industry but t...
Heterocycle-containing cyclic peptides are promising scaffolds for the pharmaceutical industry but t...
This work was supported by the European Research Council (339367), UK Biotechnology and Biological S...
Cyclic peptides possess desirable characteristics as potential pharmaceutical scaffolds. The cyanob...
We thank G. Mann and Dr. A. Bent, for supplying the enzymes and the useful discussions, and Dr. T. L...
This work was funded by the Leverhulme Trust (RPG-2012–504), BBSRC (BB/K015508/1) and the University...
Cyclic depsipeptides constitute a fascinating class of natural products. Most of them are characteri...
Acknowledgements We thank Dr. G. Mann and Dr. A. Bent for supplying the enzymes and the useful discu...
MJ, JHN, WEH, LT gratefully acknowledge support from the the Leverhulme Trust (RPG 2012-504). JT and...
My thesis focuses on the methodology and application of novel synthetic strategies for high-throughp...
H.L. is funded by the George & Stella Lee Scholarship and Criticat EPSRC. This project was also fund...
This work was supported by the European Research Council (339367), UK Biotechnology and Biological S...
Acknowledgements This work was supported by the European Research Council (339367), UK Biotechnology...
Supported by a Wellcome Trust Capital Award (086036)Ringing the changes: Selenazolines have applicat...
Heterocycle‐containing cyclic peptides are promising scaffolds for the pharmaceutical industry but t...
Heterocycle-containing cyclic peptides are promising scaffolds for the pharmaceutical industry but t...
Heterocycle-containing cyclic peptides are promising scaffolds for the pharmaceutical industry but t...
This work was supported by the European Research Council (339367), UK Biotechnology and Biological S...
Cyclic peptides possess desirable characteristics as potential pharmaceutical scaffolds. The cyanob...
We thank G. Mann and Dr. A. Bent, for supplying the enzymes and the useful discussions, and Dr. T. L...
This work was funded by the Leverhulme Trust (RPG-2012–504), BBSRC (BB/K015508/1) and the University...
Cyclic depsipeptides constitute a fascinating class of natural products. Most of them are characteri...
Acknowledgements We thank Dr. G. Mann and Dr. A. Bent for supplying the enzymes and the useful discu...
MJ, JHN, WEH, LT gratefully acknowledge support from the the Leverhulme Trust (RPG 2012-504). JT and...
My thesis focuses on the methodology and application of novel synthetic strategies for high-throughp...
H.L. is funded by the George & Stella Lee Scholarship and Criticat EPSRC. This project was also fund...
This work was supported by the European Research Council (339367), UK Biotechnology and Biological S...
Acknowledgements This work was supported by the European Research Council (339367), UK Biotechnology...
Supported by a Wellcome Trust Capital Award (086036)Ringing the changes: Selenazolines have applicat...